Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
YCJ-01
- Development stage
- Phase 3
- Lead developer
- Oils4Cure
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
**YCJ-01** is an investigational, orally administered full-spectrum *Cannabis sativa* extract developed by Oils4Cure for refractory epilepsy associated with tuberous sclerosis complex. The proprietary botanical extract is reported to contain cannabidiol and dronabinol and is being evaluated as adjunctive treatment to reduce seizure frequency. Its pharmacology is expected to reflect combined cannabinoid activity, but a product-specific target profile and quantitative constituent composition have not been publicly established. Oils4Cure's randomized, double-blind, placebo-controlled SPECTRUM study is a Phase 3 program in patients aged 2 to 65 years with treatment-refractory TSC-associated epilepsy. ([oils4cure.com](https://oils4cure.com/spectrum-clinical-trial/))
- Other names
- Cannabis Extract YCJ-01YCJ-01 Full Spectrum Cannabis ExtractYCJ01 Full Spectrum Cannabis ExtractYCJ 01 Full Spectrum Cannabis Extract
02
Targets
GPR55 (G protein-coupled receptor 55)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on YCJ-01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on YCJ-01.